The number of additional months of life expectancy for surgical patients was 8.
The sensitivity and specificity of the CXR screening programme were 54% and 97%, respectively.
55% of detected cases were amenable to surgery. The morbidity of thoracotomy was 1 month and the mortality rate was 1%.
1% of cases were lost to follow-up annually.
The annual probability of first recurrence ranged between 0.5% and 12.9%.
The proportion of systemic recurrences varied between 6% and 47%.
The proportion of asymptomatic lung recurrences varied between 15% and 38%.
Health utilities were 0.9 for surgical patients with complete remission and 0.5 for patients with progressive disease.